On the 10th of May 2017, ContextVision held its ordinary Shareholders’ Annual General Meeting in Stockholm.
– The annual financial report regarding 2016 was presented, and approved by the AGM. – Disposition of financial results according to the proposal of the Board of Directors was approved. – The Managing Director and the Board of Directors were discharged from liability. – Board compensation was decided according to the following: · The chairman of the board will be paid SEK 300.000 for the period until next AGM. · Other members of the board, whom are not also main shareholders, will be paid SEK 200.000 for the period until next AGM.– The audit fee will be based on current account. – Erik Danielsen, Magne Jordanger, Martin Hedlund, Karin Bernadotte and Sven Günther-Hanssen were reelected as board members. – No … Read More »Read More...
Please follow the link to find the latest results analysis from Norne:
2017 Maj 3
For previous analysis, visit Analyst CoverageRead More...
ContextVision: Major breakthroughs in Q1
STOCKHOLM, Sweden – April 27, 2017 – ContextVision, a world leading provider of medical image processing software, achieved a key milestone within digital pathology and is now ready to enter product development phase. The total sales during the quarter were 17,3 MSEK, which were 6,3% lower than first quarter the previous year. “This was in line with our expectations following the very strong fourth quarter last year. We are very fortunate to have a stable and core business that generates a strong cash flow to support aggressive new product development programs,” said ContextVision’s CEO, Anita Tollstadius.
Access to vast amount of samples
In March, ContextVision signed an agreement with ALAB plus, one of Poland’s largest provider of pathology services, which secured exclusive and direct access to a wealth of clinical pathology samples. This gives ContextVision access … Read More »Read More...
STOCKHOLM – April 20, 2017 – The Centre for Medical Imaging Science and Visualization (CMIV) at Linköping University is developing a new database for medical images and pathology images to offer training data for new artificial intelligence-based (AI) products. As an early partner, ContextVision and one other company, Sectra, will have the opportunity to create commercial value from the database.
A large amount of data is required for accurate training of new algorithms. This new database will facilitate the development of different AI-based systems supporting cancer-related medical imaging. The evaluation of medical images is crucial for accurate cancer care but is currently complex to manage for radiologists and pathologists due to an increasing number of images.
“Accessing images is the starting point for AI product development within medical imaging. Ensuring that ContextVision has broad access to these different … Read More »Read More...
Stockholm, April 12, 2017 The ContextVision AB:s Profit Sharing Foundation has sold and purchased shares in ContextVision AB in accordance with the rules related to the foundation. The ContextVision AB:s Profit Sharing Foundation has sold 29,300 shares during the period March 24 – April 4, at an average price of 62,05 NOK/share, in accordance with the rules related to the foundation. The sold shares were originally purchased in 2013, and according to the rules they must be sold after a period of 3 full calendar years, the year of purchase thereby not included. The net contribution after tax deductions, will be paid out to the employees. The company achieved important goals during 2016 related to sales, the operational margin within the core business of image enhancement, successful product development as well as business development activities. … Read More »Read More...
STOCKHOLM – April 10, 2017 – A consortium including ContextVision, a medical technology company specializing in image analysis and artificial intelligence, received a support grant of SEK 500 000 from the Swedish government-funded innovation agency, Vinnova.
The project serves to evaluate if deep learning can provide a more exact and more reliable analysis of the images than visual inspection. The research will focus on a well-defined group of cancer patients where PET/CT-images of before and after treatments as well as follow-ups are available.
The consortium includes the two prestigious institutions: the Royal Institute of Technology and the Karolinska Institute; as well as two commercial partners: Elekta AB and ContextVision AB.
“This is a very prominent group of skilled researchers and we are proud to be chosen as a close research partner for this project,” said Anita Tollstadius, CEO … Read More »Read More...
Stockholm, April 6th, 2017
ContextVision hereby invites shareholders to the Annual General Meeting on May 10, 2017.Please find attached the invitation including agenda and details on how to register.
Please contact: firstname.lastname@example.org for any questions regarding the AGM.
Download pdf »Read More...
Stockholm, Sweden, April 6th, 2017 – ContextVision, a world leading provider of medical image processing software presents Annual Report 2016.
Please find ContextVision’s Annual Report 2016 attached below.
For inquiries, please contact CFO Ann-Charlotte LinderothE-mail: email@example.com
Download pdf »Read More...
STOCKHOLM – March 29, 2017 – ContextVision, a medical technology company specializing in image analysis and artificial intelligence, has started a collaboration and signed an agreement with ALABplus, one of Poland’s largest provider of pathology services, to secure access to a significant amount of data for deep learning product development within digital pathology.
“The present contract is extremely valuable for ContextVision as we secure access to as much material as we need, which will boost the product development phase“, said Anita Tollstadius, CEO.
In 2015, ContextVision made the strategic decision to enter a new, rapidly growing market, digital pathology, in order to open up for a significant company growth. The company decided to become a major supplier of image analysis products and is heading a three-year Eurostar sponsored research program. In this project, the company is using … Read More »Read More...
Stockholm, Sweden – March 14, 2017 – ContextVision, a leading provider of medical imaging software specializing in image analysis and artificial intelligence, received a patent approval on a new technology for the visualization of the skeleton from 3D ultrasound. The patent was filed in 2014.
The technology is based on a visualization software and improves the potential for early discovery of skeletal irregularities in unborn babies.
This offers a unique product feature named SkeletalView which is integrated into ContextVision’s groundbreaking 3D rendering product, REALiCE, which is commercially available.
SkeletalView enables the clinicians to obtain a more accurate view of the fetal skeleton during pregnancy. This product feature helps the clinicians examine the fetus for spontaneous fractures and skeletal malformations. It also facilitates the measurement of bone structures.
“Our new visualization product REALiCE has received … Read More »Read More...